IL20 and acute lymphoblastic leukemia: The phenotypic modification of CLOCK-overexpressing T-ALL cells was featured by increased proliferative capacity, with increased cell fraction in S and G2/M phase and decreased tendency to apoptosis in response to increasing doses of IL20.